- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beta Drugs Ltd (BTAD)Beta Drugs Ltd stock price live, this page displays NS BTAD stock exchange data. View the BTAD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beta Drugs Ltd real time stock price chart below.
What Is the Beta Drugs Ltd Stock Price Today?
The Beta Drugs Ltd stock price today is 2,216.35.
What Is the Stock Symbol for Beta Drugs Ltd?
The stock symbol for Beta Drugs Ltd is "BTAD."
What Stock Exchange Does Beta Drugs Ltd Trade On?
Beta Drugs Ltd is listed and trades on the NSE stock exchange.
Is Beta Drugs Ltd a Good Stock to Buy?
Determining whether Beta Drugs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BTAD quote. (ISIN: INE351Y01019)
What Is the Beta Drugs Ltd Stock Price Today?
The Beta Drugs Ltd stock price today is 2,216.35.
What Is the Stock Symbol for Beta Drugs Ltd?
The stock symbol for Beta Drugs Ltd is "BTAD."
What Stock Exchange Does Beta Drugs Ltd Trade On?
Beta Drugs Ltd is listed and trades on the NSE stock exchange.
Is Beta Drugs Ltd a Good Stock to Buy?
Determining whether Beta Drugs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BTAD quote. (ISIN: INE351Y01019)
NSE
Currency in INR
2,216.35
-25.95(-1.16%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,216.35
2,258.00
52 wk Range
1,060.05
2,326.00
BTAD Scorecard
Full Analysis
Trading at a high earnings multiple
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,216.352,258.00
52 wk Range
1,060.052,326.00
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockBTAD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Beta Drugs Company Profile
Beta Drugs Limited develops, manufactures, and sells anti-cancer drugs in India. The company offers oncology products in the areas of breast, lung, head and neck, colorectal, ovarian, gastric, testicular, renal, and prostate cancer, as well as brain tumor, leukemia, lymphoma, myeloma, and supportive cancer; and dermatology products. It also develops active pharmaceutical ingredients. The company exports its products. Beta Drugs Limited was incorporated in 2005 and is based in Panchkula, India.
Compare BTAD to Peers and Sector
Metrics to compare | BTAD | Peers Peers - average of corresponding metrics from companies closely matching BTAD: NEULANDLAB, PPLPHARMA, NECLIFE, 524414, 524314 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBTADPeersSector |
|---|---|---|---|---|
P/E Ratio | 52.6x | 20.1x | −0.7x | |
PEG Ratio | 2.87 | 0.19 | 0.00 | |
Price/Book | 11.9x | 3.5x | 2.6x | |
Price / LTM Sales | 6.4x | 3.3x | 3.2x | |
Upside (Analyst Target) | - | −1.5% | 46.4% | |
Fair Value Upside | Unlock | −22.1% | 6.9% | Unlock |
FAQ
What Is the Beta Drugs (BTAD) Stock Price Today?
The Beta Drugs stock price today is 2,216.35.
What Stock Exchange Does Beta Drugs Trade On?
Beta Drugs is listed and trades on the NSE stock exchange.
What Is the Stock Symbol for Beta Drugs?
The stock symbol for Beta Drugs is "BTAD."
What Is the Beta Drugs Market Cap?
As of today, Beta Drugs market cap is 21.56B.
What is Beta Drugs Earnings Per Share?
The Beta Drugs EPS is 42.65.
From a Technical Analysis Perspective, Is BTAD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.